Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 121 AL 135

A single ascending dose study of bapineuzumab in patients with Alzheimer disease

Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, Grundman M.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):198-203. doi: 10.1097/WAD.0b013e3181c53b00.

APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics

Hussain I.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):395-402. doi: 10.2174/187152710791556087.

Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)

Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B; PLASA Group.

BMJ. 2010 Jun 3;340:c2466. doi: 10.1136/bmj.c2466.

Care plans for people with Alzheimer's disease

Schneider LS.

BMJ. 2010 Jun 3;340:c2626. doi: 10.1136/bmj.c2626.

Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia

Wang Y, Huang LQ, Tang XC, Zhang HY.

Acta Pharmacol Sin. 2010 Jun;31(6):649-64. doi: 10.1038/aps.2010.46.

Tacrine-NO donor and tacrine-ferulic acid hybrid molecules as new anti-Alzheimer agents: hepatotoxicity and influence on the cytochrome P450 system in comparison to tacrine

Lupp A, Appenroth D, Fang L, Decker M, Lehmann J, Fleck C.

Arzneimittelforschung. 2010;60(5):229-37. doi: 10.1055/s-0031-1296278.

Meeting report: the 7th Leonard Berg Symposium, part 1

Strobel G.

J Alzheimers Dis. 2010;20(3):943-8. doi: 10.3233/JAD-2010-100013.

Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease

Hung CH, Ho YS, Chang RC.

Ageing Res Rev. 2010 Oct;9(4):447-56. doi: 10.1016/j.arr.2010.05.003. Epub 2010 May 27.

Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation

Bar-Am O, Amit T, Weinreb O, Youdim MB, Mandel S.

J Alzheimers Dis. 2010;21(2):361-71. doi: 10.3233/JAD-2010-100150.

[Colivelin--drug therapy for patients with Alzheimer's disease]

Matsuoka M.

Nihon Yakurigaku Zasshi. 2010 Jun;135(6):263.

Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities

Rosenblatt A, Gao J, Mackell J, Richardson S.

Am J Alzheimers Dis Other Demen. 2010 Sep;25(6):483-9. doi: 10.1177/1533317510372923. Epub 2010 Jun 17.

REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state

Panza F, Frisardi V, Imbimbo BP, Capurso C, Logroscino G, Sancarlo D, Seripa D, Vendemiale G, Pilotto A, Solfrizzi V.

CNS Neurosci Ther. 2010 Oct;16(5):272-84. doi: 10.1111/j.1755-5949.2010.00164.x. Epub 2010 Jun 16.

Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?

Martorana A, Esposito Z, Koch G.

CNS Neurosci Ther. 2010 Aug;16(4):235-45. doi: 10.1111/j.1755-5949.2010.00175.x. Epub 2010 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias